Search: id:"swepub:oai:gup.ub.gu.se/290192" >
Antiretroviral trea...
Antiretroviral treatment for HIV infection: Swedish recommendations 2019
-
- Eriksen, J. (author)
- Karolinska Institutet
-
- Carlander, C. (author)
- Karolinska Institutet
-
- Albert, J. (author)
- Karolinska Institutet
-
show more...
-
Flamholc, L. (author)
-
- Gisslén, Magnus, 1962 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine
-
- Naver, L. (author)
- Karolinska Institutet
-
- Svedhem, V. (author)
- Karolinska Institutet
-
- Yilmaz, Aylin, 1974 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine
-
- Sonnerborg, A. (author)
- Karolinska Institutet
-
show less...
-
(creator_code:org_t)
- 2020-01-11
- 2020
- English.
-
In: Infectious Diseases. - : Informa UK Limited. - 2374-4235 .- 2374-4243. ; 52:5, s. 295-329
- Related links:
-
https://www.tandfonl...
-
show more...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- The Swedish Reference Group for Antiviral Therapy (RAV) published recommendations for the treatment of HIV infection in this journal most recently in 2017. An expert group under the guidance of RAV here provides updated recommendations. The most important updates in the present guidelines are the following: (a) The risk of HIV transmission through condomless sex from individuals with fully suppressed HIV viral load is effectively zero. (b) Pre-exposure prophylaxis (PrEP) is recommended for groups with a high risk of HIV infection. (c) Since the last update, two new substances have been registered: bictegravir and doravirine. (d) Dual treatment may be an alternative in selected patients, using lamivudine + dolutegravir or lamivudine + boosted darunavir/atazanavir. As with previous publications, recommendations are evidence-graded in accordance with the Oxford Centre for Evidence Based Medicine. This document does not cover treatment of opportunistic infections and tumours.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Keyword
- Antiretroviral
- HIV
- treatment guidelines
- Sweden
- adult
- paediatric
- tenofovir disoproxil fumarate
- cervical intraepithelial neoplasia
- human-papillomavirus vaccine
- randomized double-blind
- once-daily
- dolutegravir
- public-health agency
- short-term risk
- initial treatment
- hiv-1-infected patients
- drug-resistance
- Infectious Diseases
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Eriksen, J.
-
Carlander, C.
-
Albert, J.
-
Flamholc, L.
-
Gisslén, Magnus, ...
-
Naver, L.
-
show more...
-
Svedhem, V.
-
Yilmaz, Aylin, 1 ...
-
Sonnerborg, A.
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Infectious Medic ...
- Articles in the publication
-
Infectious Disea ...
- By the university
-
University of Gothenburg
-
Karolinska Institutet